Isabelle de Cremoux

• Highlight data-driven milestones that attract funding to unlock capital
• Structure deals to balance risk and reward for early-stage ventures to improve term-sheet appeal
• Position platforms for scalability and exit potential to attract strategic investment

Key Session

This dynamic session offers a platform for early-stage microbiome companies to pitch their technologies to a panel of investors, pharma scouts, and industry experts. Designed to foster visibility, feedback, and potential partnerships, each presentation is followed by live commentary and audience engagement.